Concepedia

A bibliometric evaluation of the top 100 cited natalizumab articles

Francisco Javier García-Fernández, Alba-Estela Garcia-Fernandez, Eduardo Nava, Julián Solís García del Pozo, Ichiro Ikuta, Joaquı́n Jordán, Marı́a F. Galindo

Journal of Neuroimmunology · 2020 · 15 citations · 5 references

DOI

Concepts

References

5

A Randomized, Placebo-Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis

Chris H. Polman, Paul O’Connor, Eva Havrdová et al. · New England Journal of Medicine · 2006 · 3.3K citations · Full text

, , +14

A Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis

David H. Miller, Omar Khan, William Sheremata et al. · New England Journal of Medicine · 2003 · 1.2K citations · Full text

, , +16

Progressive Multifocal Leukoencephalopathy Complicating Treatment with Natalizumab and Interferon Beta-1a for Multiple Sclerosis

Bette K. Kleinschmidt‐DeMasters, Kenneth L. Tyler · New England Journal of Medicine · 2005 · 1.1K citations · Full text

, , +12

Cutting Edge: Natalizumab Blocks Adhesion but Not Initial Contact of Human T Cells to the Blood-Brain Barrier In Vivo in an Animal Model of Multiple Sclerosis

Caroline Coisne, Wenxian Mao, Britta Engelhardt · The Journal of Immunology · 2009 · 114 citations

, , +17

Evaluation of natalizumab pharmacokinetics and pharmacodynamics with standard and extended interval dosing

John Foley, Susan Goelz, Tamara Hoyt et al. · Multiple Sclerosis and Related Disorders · 2019 · 55 citations

, , +11